ali almasirad

ali almasirad


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AAali almasirad
ali almasirad
STSayyed A. Tabatabai
Sayyed A. Tabatabai
MFMehrdad Faizi
Mehrdad Faizi
AKAbbas Kebriaeezadeh
Abbas Kebriaeezadeh
NMNazila Mehrabi
Nazila Mehrabi
ASAbbas Shafiee
Abbas Shafiee

18 March 2010 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
AAali almasirad
ali almasirad
ASAbbas Shafiee
Abbas Shafiee
MAMohammad Abdollahi
Mohammad Abdollahi
ANAmir Noeparast
Amir Noeparast
NSNasir Shahrokhinejad
Nasir Shahrokhinejad
RKReza Khorasani
Reza Khorasani

22 January 2014 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
AAali almasirad
ali almasirad
ZMZahra Mousavi
Zahra Mousavi
MTMohammad Tajik
Mohammad Tajik
MAMohammad Javad Assarzadeh
Mohammad Javad Assarzadeh
ASAbbas Shafiee
Abbas Shafiee
Long-term clinical employment of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with significant side effects including gastrointestinal (GI) lesions and kidney toxicity. In this paper we designed and synthesized new imidazolyl-1,3,4-oxadiazoles and 1,2,4-triazoles by molecular hybridization of previously described anti-inflammatory compounds in the hope of obtaining new safer analgesic and anti-inflammatory agents. The target structures were synthesized by preparation of 5-methyl-1H-imidazole-4-carboxylic acid ethyl ester 5. The reaction of hydrazine hydrate with this ester afforded the 5-methyl-1H-imidazole-4-carboxylic acid hydrazide 6 which was converted to target compounds 7-15 according to the known procedures. In silico toxicity risk assessment and drug likeness predictions were done, in order to consider the privileges of the synthesized structures as drug candidates. The analgesic and anti-inflammatory profile of the synthesized compounds were evaluated by writhing and carrageenan induced rat paw edema tests respectively. Compounds 8, 9 and 11-13 and 15 were active analgesic agents and compounds 8, 9 and 11-13 showed significant anti-inflammatory response in comparison with control. Compounds 11 and 13 were screened for their ulcerogenic activities and none of them showed significant ulcerogenic activity. The active Compounds 11 and 12 showed the highest drug likeness and drug score. The analgesic and anti-inflammatory activities of title compounds were comparable to that of standard drug indomethacin with a safer profile of activity. The results revealed that both of oxadiazole and triazole scaffolds can be determined as pharmacophores. The in silico predictions and pharmacological evaluations showed that compounds 11 and 12 can be chosen as lead for further investigations.

1 November 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
RTRaheleh Tahmasvand
Raheleh Tahmasvand
PBPeyman Bayat
Peyman Bayat
SVSeyyed Mahmood Vahdaniparast
Seyyed Mahmood Vahdaniparast
SDSoudeh Dehghani
Soudeh Dehghani
ZKZahra Kooshafar
Zahra Kooshafar
MSMona Salimi
Mona Salimi

21 August 2013 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
MAMohammad Javad Assarzadeh
Mohammad Javad Assarzadeh
AAali almasirad
ali almasirad
ASAbbas Shafiee
Abbas Shafiee
MKMansur Nassiri Koopaei
Mansur Nassiri Koopaei
MAMohammad Abdollahi
Mohammad Abdollahi

1 January 2006 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
AAali almasirad
ali almasirad
RHRohollah Hosseini
Rohollah Hosseini
HJHassan Jalalizadeh
Hassan Jalalizadeh
ZRZohreh Rahimi-Moghaddam
Zohreh Rahimi-Moghaddam
NANazila Abaeian
Nazila Abaeian
ASAbbas Shafiee
Abbas Shafiee
A series of 2-phenoxybenzoic acid and N-phenylanthranilic acid hydrazides were synthesized and evaluated for their analgesic activities. Several compounds were significantly more potent than mefenamic acid and diclofenac sodium in abdominal constriction and formalin tests.